glycine has been researched along with Coronary Artery Disease in 18 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Leonurine has been shown to have excellent anti-myocardial ischemia effects." | 8.12 | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver-Cardiac Crosstalk Metabolomics Study. ( Li, J; Lu, Q; Pan, D; Rong, W; Wang, A; Wang, L; Zhang, Y; Zhou, Q; Zhu, Q; Zhu, Y, 2022) |
| "To investigate the causal role of choline metabolites mediating sodium-glucose cotransporter 2 (SGLT2) inhibition in coronary artery disease (CAD) and type 2 diabetes (T2D) using Mendelian randomization (MR)." | 5.22 | SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study. ( Bi, Y; Hou, T; Li, M; Lin, H; Lu, J; Ning, G; Wang, S; Wang, T; Wang, W; Xu, M; Xu, Y; Zhao, Z; Zheng, J, 2022) |
| "Leonurine has been shown to have excellent anti-myocardial ischemia effects." | 4.12 | Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver-Cardiac Crosstalk Metabolomics Study. ( Li, J; Lu, Q; Pan, D; Rong, W; Wang, A; Wang, L; Zhang, Y; Zhou, Q; Zhu, Q; Zhu, Y, 2022) |
| "We conducted a genome-wide association study (GWAS) in Singaporean Chinese participants and investigated if genetically determined serum glycine were associated with incident coronary artery disease (CAD) (711 cases and 1,246 controls), cardiovascular death (1,886 cases and 21,707 controls) and angiographic CAD severity (as determined by the Modified Gensini score, N = 1,138)." | 4.02 | The association of genetically determined serum glycine with cardiovascular risk in East Asians. ( Chan, MY; Chang, X; Dorajoo, R; Friedlander, Y; Guan, SP; Heng, CK; Kennedy, BK; Khor, CC; Koh, WP; Liu, J; Low, AF; Wang, L; Yuan, JM, 2021) |
| "Unstable coronary artery disease is in most cases associated with plaque rupture, activation of the coagulation system and subsequent intracoronary thrombus formation which may cause myocardial cell damage." | 2.71 | Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease. ( Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Thygesen, K; Wallentin, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, M | 1 |
| Zheng, J | 1 |
| Hou, T | 1 |
| Lin, H | 1 |
| Wang, T | 1 |
| Wang, S | 1 |
| Lu, J | 1 |
| Zhao, Z | 1 |
| Li, M | 1 |
| Xu, Y | 1 |
| Ning, G | 1 |
| Bi, Y | 1 |
| Wang, W | 1 |
| Rong, W | 1 |
| Li, J | 1 |
| Pan, D | 1 |
| Zhou, Q | 1 |
| Zhang, Y | 1 |
| Lu, Q | 1 |
| Wang, L | 2 |
| Wang, A | 1 |
| Zhu, Y | 1 |
| Zhu, Q | 1 |
| Chang, X | 1 |
| Guan, SP | 1 |
| Kennedy, BK | 1 |
| Liu, J | 1 |
| Khor, CC | 1 |
| Low, AF | 1 |
| Chan, MY | 1 |
| Yuan, JM | 1 |
| Koh, WP | 1 |
| Friedlander, Y | 1 |
| Dorajoo, R | 1 |
| Heng, CK | 1 |
| Jia, Q | 1 |
| Han, Y | 1 |
| Huang, P | 1 |
| Woodward, NC | 1 |
| Gukasyan, J | 1 |
| Kettunen, J | 1 |
| Ala-Korpela, M | 1 |
| Anufrieva, O | 1 |
| Wang, Q | 1 |
| Perola, M | 1 |
| Raitakari, O | 1 |
| Lehtimäki, T | 1 |
| Viikari, J | 1 |
| Järvelin, MR | 1 |
| Boehnke, M | 1 |
| Laakso, M | 1 |
| Mohlke, KL | 1 |
| Fiehn, O | 1 |
| Wang, Z | 1 |
| Tang, WHW | 1 |
| Hazen, SL | 1 |
| Hartiala, JA | 1 |
| Allayee, H | 1 |
| Jahangir, E | 1 |
| Vita, JA | 1 |
| Handy, D | 1 |
| Holbrook, M | 1 |
| Palmisano, J | 1 |
| Beal, R | 1 |
| Loscalzo, J | 1 |
| Eberhardt, RT | 1 |
| Geloneze, SR | 1 |
| Geloneze, B | 1 |
| Morari, J | 1 |
| Matos-Souza, JR | 1 |
| Lima, MM | 1 |
| Chaim, EA | 1 |
| Pareja, JC | 1 |
| Velloso, LA | 1 |
| Kucukhuseyin, O | 1 |
| Yilmaz-Aydogan, H | 1 |
| Isbir, CS | 1 |
| Isbir, T | 1 |
| Chan, SH | 1 |
| Chen, JH | 1 |
| Li, YH | 1 |
| Tsai, LM | 1 |
| Narne, P | 1 |
| Ponnaluri, KC | 1 |
| Singh, S | 1 |
| Siraj, M | 1 |
| Ishaq, M | 1 |
| MUNE, N | 1 |
| Linder, R | 2 |
| Frebelius, S | 1 |
| Grip, L | 2 |
| Swedenborg, J | 1 |
| Ameziane, N | 1 |
| Beillat, T | 1 |
| Verpillat, P | 1 |
| Chollet-Martin, S | 1 |
| Aumont, MC | 1 |
| Seknadji, P | 1 |
| Lamotte, M | 1 |
| Lebret, D | 1 |
| Ollivier, V | 1 |
| de Prost, D | 1 |
| Oldgren, J | 1 |
| Siegbahn, A | 1 |
| Thygesen, K | 1 |
| Wallentin, L | 1 |
| Hemdahl, AL | 1 |
| Falk, E | 1 |
| Thorén, P | 1 |
| Hansson, GK | 1 |
| Salam, AM | 1 |
| Al-Mousa, EN | 1 |
| Gross, CM | 1 |
| Krämer, J | 1 |
| Pfeufer, A | 1 |
| Dietz, R | 1 |
| Gessner, R | 1 |
| Praus, M | 1 |
| Leineweber, K | 1 |
| Bogedain, P | 1 |
| Wolf, C | 1 |
| Wagner, S | 1 |
| Weber, M | 1 |
| Jakob, HG | 1 |
| Heusch, G | 1 |
| Philipp, T | 1 |
| Brodde, OE | 1 |
| Nordestgaard, BG | 1 |
| Abildgaard, S | 1 |
| Wittrup, HH | 1 |
| Steffensen, R | 1 |
| Jensen, G | 1 |
| Tybjaerg-Hansen, A | 1 |
3 reviews available for glycine and Coronary Artery Disease
| Article | Year |
|---|---|
SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
Topics: Choline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Genome-Wide Association Study; Glycine; | 2022 |
Genetic Determinants of Circulating Glycine Levels and Risk of Coronary Artery Disease.
Topics: Biomarkers; Coronary Artery Disease; Female; Genetic Loci; Genetic Predisposition to Disease; Genome | 2019 |
The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials.
Topics: Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Clinical Trials as Topic; Coronary Ar | 2004 |
2 trials available for glycine and Coronary Artery Disease
| Article | Year |
|---|---|
The effect of L-arginine and creatine on vascular function and homocysteine metabolism.
Topics: Aged; Arginine; Brachial Artery; Coronary Artery Disease; Creatine; Dietary Supplements; Female; Gly | 2009 |
Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Coronary Artery Disease; Glycine; Heparin; Humans; Middl | 2004 |
13 other studies available for glycine and Coronary Artery Disease
| Article | Year |
|---|---|
Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver-Cardiac Crosstalk Metabolomics Study.
Topics: Amino Acids; Animals; Coronary Artery Disease; Fatty Acids; Glycine; Liver; Metabolomics; Myocardial | 2022 |
The association of genetically determined serum glycine with cardiovascular risk in East Asians.
Topics: Asian People; Biomarkers; Carbamoyl-Phosphate Synthase (Ammonia); Case-Control Studies; China; Coron | 2021 |
PGC1α gene Gly482Ser polymorphism predicts improved metabolic, inflammatory and vascular outcomes following bariatric surgery.
Topics: Adolescent; Adult; Brazil; C-Reactive Protein; Carotid Intima-Media Thickness; Comorbidity; Coronary | 2012 |
Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?
Topics: Coronary Artery Disease; Demography; Diabetes Complications; Female; Gene Frequency; Genetic Associa | 2012 |
Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population.
Topics: Aged; Alleles; Asian People; Coronary Angiography; Coronary Artery Disease; Female; Gene Frequency; | 2012 |
Arg399Gln polymorphism of X-ray repair cross-complementing group 1 gene is associated with angiographically documented coronary artery disease in South Indian type 2 diabetic patients.
Topics: Arginine; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; DNA-Binding Prot | 2013 |
[Betasyamine in therapy of coronary arteriosclerosis].
Topics: Acetates; Arteriosclerosis; Coronary Artery Disease; Glycine | 1954 |
The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
Topics: Amino Acid Chloromethyl Ketones; Anticoagulants; Azetidines; Benzylamines; Clinical Trials as Topic; | 2003 |
Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.
Topics: Acute Disease; Adult; Aged; Alleles; Amino Acid Substitution; Aspartic Acid; Case-Control Studies; C | 2003 |
Thrombin inhibitor reduces myocardial infarction in apoE-/- x LDLR-/- mice.
Topics: Animals; Apolipoproteins E; Azetidines; Benzylamines; Biomarkers; Coronary Artery Disease; Coronary | 2004 |
The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis.
Topics: Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Female; Follow-Up Studies; Ge | 2004 |
In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.
Topics: Adrenergic beta-Antagonists; Aged; Arginine; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; | 2007 |
Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Asparagine; Cholesterol, HDL; Coronary Artery Di | 1997 |